The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
... whats more worrying is if they have nothing positive to update ... But historically the PR/News drip has been very slow hence there is very little excitement/hype around CPT. SP drop today down to???? Been buys going through. Market is getting impatient I think with CPT, saying all the right things but only sales will shift this now
Was c.75% of all traded yesterday and didn't push the SP ... But a good buy and hopefully someone has wind of something - an update must be soon
Need that sales RNS ... but she is holding steady despite the media hype on share doom! Come on CPT ... x5 new distributors and �xxM sales pipeline Its coming trust me
Certainly does! This share is so under the radar ... honestly believe it will move big and quick once new distributors are on board and sales start ramping up, then there is EU ... we are on the cusp. Still could go either way ... but odds are more and more in our favour
Yep good start Craig ... I thought this would happen yesterday, but happy to see it, but we need to get some momentum and get this 10p+ pronto!
Yep good start Craig ... I thought this would happen yesterday, but happy to see it, but we need to get some momentum and get this 10p+ pronto!
The evaluation also included a comparison with a leading home test. As myLotus also provides quantitative results, the evaluation showed that it is possible for women who commonly experience weaker positives to ascertain exactly when they are about to ovulate much more accurately in comparison to using the existing commercially available home tests. So 100% match to hospital test. Meaning users don't need to go into hospital instead they can use MyLotus And ... we are much more accurate to what's currently commercially available
Has to be distributer sign ups and orders. It�s the next milestone and if it comes the SP will start to rapidly move ... I firmly believe it will come, Erik has assured us the team are on the ground working hard. Patience is still key here. Remember we did have the �600k order pre Christmas and they won�t RNS every order. So ... product proved to be 100% viable and Erik saying all the right things. Next step sales or I still think a JV / buy out is still a possible scenario. Today�s RNS ... is interesting as they had already stated that the tests had a 100% match to hospital trials. The really exciting part was how favourable / better we are than the nearest competing product. Exciting times ahead. Bit more patience required. God speed CPT
MikG agree ... bodes well Looks like a high price buy, may see us open blue tomorrow. Despite the timing delays I've always believed in this share. Hopefully that belief will now start to pay back
I should say I�m going to be off this board for a bit more often : ) Great news. Confirmation we are viable. Huge step. Agree with Jimbo and others that confirmed distributors and sales will really move this. For me the only negative here is we are way behind original timescales. I can live with that. Logic says ... if product is viable and there is a clear market need then Sales will follow. May take another 6-8 weeks for a meaningful update ... Holding happy. Jigsaw coming together, bit more patience needed ... good luck to all and special mention to all the LTHs
No depression here! Good times ahead I don�t tend to read your posts, just skim them tbh, sorry if I missed something in your negativity cloud. Fully entitled to your views obviously, but not sure why you are here if all you have to say is negative. Anyway all the best to you and have a fab weekend. I�m off the board now on holidays for a bit
Time for positive vibes has passed ... we have had those and banked them. Now only two things matter in the short term ... xx new Chinese distributors and �xxM of confirmed oders or pipeline ... Anything else is just guff Erik and CPTs last update - launch positive, test results positive, now distributors will be contacted. They either want the product or they don't. Its Do or Die time for this.
Or is this fools gold ... ? Time will tell ... it�s certainly been a long wait
Done @0.068p Personally I think that is a crazy price. I�m done now, no more top ups. Holding and waiting now. Back to 7p ask now as per the placing. It can�t go lower ... IMO ... based on the �2m raised, they would have purchased based on a confidence level that 7p is the anchor. Question now is ... do we have more distributors and sales? If so ... is EU feasible? If so ... are we a buy out target at c20p ... or where can this SP go ... All conjecture. RNS please CPT ... growing distributors and confirmed sales ...
Nothing new here, but good insight on EU potential Focus on Europe Concepta�s Board, with support from documented research and learned papers, estimates that the target market in the EU comprises some 1.7 million women who have been unsuccessfully trying for a baby in excess of six months. Based on expected meter unit pricing plus typical batches of test strips, this equates to an annual market potential of �350 million. In addition to this, the product could be applied to women otherwise destined to use IVF (See Appendix 2.0); given there are over 500,000 IVF procedures annually in the EU, this amounts to a potential additional revenue stream of �62 million. Concepta has commenced its application for CE Marking, which is a formal requirement to permit such sales in the EU. The Group intends to focus initially on its home market in the UK, and will target online sales direct to consumers rather than through retail channels. Marketing activities will centre on dedicated websites for infertile women, specialised publications, help and support groups and specialised consumer fertility exhibitions. Achievement of CE marking will allow similar roll-out into other EU markets. Intellectual Property, Trademarks and Patents: Concepta�s main patent application looks at the use of the LH surge to estimate fertilisation date as well as hCG progression tracking, to establish it remains within a healthy range. Its sole patent family, which includes a pending international patent application plus a separate application in the UK, is currently being processed and remains in review. Concepta has trademarks in Europe granted for MyLotus, Lotus, Concepta, and its lotus flower logo. Applications for similar titles are ongoing in Japan, Taiwan and China. The MyLotus Meter design along with its strip design has been protected using intellectual property rights. This means that the public design and shapes of Concepta�s products cannot be lawfully copied. Application for design right protection have been filed in Europe, Japan, Taiwan, India and China and for these the European Designs have been registered. Anti-counterfeiting measures have been added to Concepta�s system to prevent competitors from copying its devices. Concepta is keeping, and intends to treat its know-how on the basis of �trade secret� and will therefore not specifically publish or detail this IP.
If the ask drops below 7p then I'm going to top up my holding ....
sorry to the ladies on the board ... should off rounded that comment with ... Never tell the Mrs or the Hubby!
I'm tempted at 7p to top up my holding, but already in at my self imposed level. Will do some sums ... risk v reward without parting with money you cant afford to lose is key ... and never ... ever tell the Mrs : )
just over 7p - you are in a good spot. I'm way above that! But its a long game ...
Good shout on getting in now, no spare funds here! Based on what we know and as you say 2018 fully funded - risk is lowered and potential is huge Still a gamble however, but a very calculated one, not a blind punt